STOCK TITAN

AMGEN ANNOUNCES WEBCAST OF 2024 FIRST QUARTER FINANCIAL RESULTS

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Amgen will report its first quarter 2024 financial results on May 2, 2024, followed by a conference call with the investment community. The webcast will be available on their website for replay for at least 90 days after the event.

Amgen presenterà i risultati finanziari del primo trimestre del 2024 il 2 maggio 2024, seguiti da una conferenza telefonica con la comunità degli investitori. La trasmissione sarà disponibile sul loro sito web per la riproduzione per almeno 90 giorni dopo l'evento.
Amgen reportará sus resultados financieros del primer trimestre de 2024 el 2 de mayo de 2024, seguido por una llamada de conferencia con la comunidad inversora. La transmisión estará disponible en su sitio web para repetición por al menos 90 días después del evento.
Amgen은 2024년 5월 2일에 2024년 제1분기 재무 결과를 발표할 예정이며, 투자자 커뮤니티와의 컨퍼런스 콜이 이어집니다. 웹캐스트는 행사 후 최소 90일 동안 그들의 웹사이트에서 다시 볼 수 있습니다.
Amgen publiera ses résultats financiers pour le premier trimestre 2024 le 2 mai 2024, suivis d'une conférence téléphonique avec la communauté des investisseurs. La webdiffusion sera disponible sur leur site web pour replay pendant au moins 90 jours après l'événement.
Amgen wird am 2. Mai 2024 die Finanzergebnisse für das erste Quartal 2024 bekannt geben, gefolgt von einer Telefonkonferenz mit der Investorengemeinschaft. Die Webübertragung wird mindestens 90 Tage nach der Veranstaltung auf ihrer Website zur Wiedergabe verfügbar sein.
Positive
  • None.
Negative
  • None.

THOUSAND OAKS, Calif., April 29, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2024 financial results on Thursday, May 2, 2024, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 4:30 p.m. ET. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. 

About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.

In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.

For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, TikTok, YouTube and Threads

CONTACT: Amgen, Thousand Oaks
Jessica Akopyan, 805-440-5721 (media)
Elissa Snook, 609-251-1407 (media)
Justin Claeys, 805-313-9775 (investors)

Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2024-first-quarter-financial-results-302130364.html

SOURCE Amgen

FAQ

When will Amgen report its first quarter 2024 financial results?

Amgen will report its first quarter 2024 financial results on May 2, 2024.

Who will participate in the conference call from Amgen?

Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team will participate in the conference call.

Where can the webcast of the financial results be found?

The webcast can be found on Amgen's website, www.amgen.com, under Investors.

How long will the webcast be available for replay?

The webcast will be available for replay for at least 90 days after the event.

Amgen Inc.

NASDAQ:AMGN

AMGN Rankings

AMGN Latest News

AMGN Stock Data

171.14B
534.35M
0.25%
80.73%
1.95%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
THOUSAND OAKS

About AMGN

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.